1. ScholarBank@NUS

Wai Ping Yau

rp10092

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wai Ping Yau
Variants
Yau, W.-P.
 
Main Affiliation
 
Faculty
 
Email
phaywp@nus.edu.sg
 

Publications

Results 1-19 of 19 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
11-Oct-2021Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practiceNaganathar, N; Yau, WP ; Mok, ZH; Tan, ZYF; Chew, STH 
2Nov-2013Assessment of antihistamine use in early pregnancy and birth defectsLi, Q.; Mitchell, A.A.; Werler, M.M.; Yau, W.-P. ; Hernández-Díaz, S.
38-Nov-2021Association between family history and lung cancer risk among Chinese women in SingaporeYin, Xin; Chan, Cheryl Pui Yi; Seow, Adeline ; Yau, Wai-Ping ; Seow, Wei Jie 
42020Association between metabolites and the risk of lung cancer: A systematic literature review and meta-analysis of observational studiesLee, K.B.; Ang, L.; Yau, W.-P. ; Seow, W.J. 
51-Apr-2002Chiral CE separation of warfarin in albumin containing samplesYau, W.-P. ; Chan, E. 
61-Jul-2016Conversion from twice-daily prograf to once-daily advagraf in multi-ethnic asian adult renal transplant recipients with or without concomitant use of diltiazem - impact of CYP3A5 genetic polymorphism on tacrolimus pharmacokineticsYau, Wai-Ping ; Vathsala, Anantharaman 
71-Jan-2018CONVERSION FROM TWICE-DAILY PROGRAF<SUP>®</SUP> TO ONCE-DAILY ADVAGRAF<SUP>®</SUP> IN MULTI-ETHNIC ASIAN ADULT RENAL TRANSPLANT RECIPIENTS WITH OR WITHOUT CONCOMITANT USE OF DILTIAZEM: IMPACT OF CYP3A5 AND MDR1 GENETIC POLYMORPHISMS ON TACROLIMUS EXPOSUREYau, WP ; Loh, CWT; Vathsala, A 
81-Oct-2003Current trends in modern pharmaceutical analysis for drug discoveryKoh, H.-L. ; Yau, W.-P. ; Ong, P.-S. ; Hegde, A.
9Nov-2011Drug certainty-response in interview-based studiesYau, W.-P. ; Lin, K.J.; Werler, M.M.; Louik, C.; Mitchell, A.A.; Hernández-Díaz, S.
10Aug-2003Enantioseparation of warfarin and its metabolites by capillary zone electrophoresisZhou, Q.; Yau, W.-P. ; Chan, E. 
111-Dec-2007Is a standard fixed dose of mycophenolate mofetil ideal for all patients?Yau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Chan, Eli 
12Sep-2012Maternal exposure to amoxicillin and the risk of oral cleftsLin, K.J.; Mitchell, A.A.; Yau, W.-P. ; Louik, C.; Hernández-Díaz, S.
131-Jun-2009Mechanism-Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant PatientsYau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Zhou, Shufeng; Chan, Eli 
141-Dec-2020ORAL BISPHOSPHONATE USE IN OLDER PATIENTS WITH REDUCED RENAL FUNCTION: CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICENaganathar, N; Yau, WP ; Mok, ZH; Tan, ZYF; Chew, THS 
15Mar-2013Safety of macrolides during pregnancyLin, K.J.; Mitchell, A.A.; Yau, W.-P. ; Louik, C.; Hernández-Díaz, S.
165-Jun-2004Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urineYau, WP ; Vathsala, A ; Lou, HX; Chan, E 
171-Feb-2007Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasmaYau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Chan, Eli 
1815-Jul-2013Use of decongestants during pregnancy and the risk of birth defectsYau, W.-P. ; Mitchell, A.A.; Lin, K.J.; Werler, M.M.; Hernández-Díaz, S.
192019Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort StudyYeo, S.-H.; Kong, K.H.; Lim, D.C.-K.; Yau, W.-P.